Lipid management across Europe in the real-world setting: a rapid evidence review

CONCLUSIONS: LDL-C control is suboptimal and the available LLT armamentarium, most importantly combination therapy, is being underutilized in high/very high risk patients leading to inadequate management of cardiovascular risk.PMID:34517739 | DOI:10.1080/03007995.2021.1973396

Source: Current Medical Research and Opinion - September 14, 2021 Category: Research Authors: Vivencio Barrios Jarkko Soronen Angela M Carter Anastassia Anastassopoulou Source Type: research